Summary Several studies carried out during the past two decades have investigated the effect of dietary and surgical manipulation on pancreatic growth and carcinogenesis. Diets high in trypsin inhibitor stimulate pancreatic growth and increase the formation of preneoplastic lesions and carcinomas in the rat pancreas. Cholecystokinin (CCK) is the key intermediary in this response, since both natural and synthetic trypsin inhibitors increase circulating levels of the hormone and CCK antagonists largely prevent these changes. Fatty acids enhance pancreatic carcinogenesis in both rats and hamsters, whereas protein appears to have a protective role in the rat, but to increase tumour yields in the hamster. Several surgical operations affect the pancreas. Pancreatobiliary diversion and partial gastrectomy stimulate pancreatic growth and enhance carcinogenesis, probably by means of increased CCK release. Complete duodenogastric reflux has similar effects on the pancreas but the gut peptide involved is gastrin. Although massive small bowel resection increases pancreatic growth, the marked reduction in caloric absorption probably explains its failure to enhance carcinogenesis. CCK and enteroglucagon might work in concert to modulate the tropic response of the pancreas to small bowel resection. In the pancreas, as in the large intestine, hyperplasia appears to precede and predispose to neoplasia.
Among the common gastrointestinal cancers, adenocarcinoma of the pancreas offers a particularly poor prognosis, rivalled only by adenocarcinoma of the gallbladder. The incidence of pancreatic cancer has doubled in Western Europe and more than quadrupled in Japan over the past 40 years (Gordis & Gold, 1984; Muir et al., 1987; Fontham & Correa, 1989; Hirayama, 1989) . Leaving aside the uncommon cystic and neuroendocrine tumours, the overall cure rate for 'ordinary' (ductal) carcinoma is barely 1%. This tumour has a number of unfavourable features: an uncertain aetiology, an aggressive biological behaviour, the lack of an obvious population to screen, and a delay in the onset of symptoms so that metastasis has generally occurred by the time of presentation (Williamson, 1988) . Moreover, current treatments are unsatisfactory. Ductal cancers seldom respond to irradiation or chemotherapy and surgical resection involves a major operation, even though the surgical risk has diminished sharply during the last decade (Watanapa & Williamson, 1992a) . Sadly, postoperative recurrence is the norm with 5-year survival rates seldom exceeding 5%.
It is against this dismal background that aetiological studies of pancreatic cancer assume a special importance; if cure is so elusive, prevention should offer a more promising tack. Epidemiological studies provide a few positive associations: increasing age, the male sex, a black skin, cigarette smoking and possibly diabetes and alcoholism (Gordis & Gold, 1984; Mills et al., 1988; Cuzick & Babiker, 1989) . It seems probable that dietary factors underlie the prevalence of this disease in Western populations and that humoral mechanisms are involved. Various gastrointestinal hormones have profound effects on the structure and function of the exocrine pancreas and thus might plausibly act as intermediaries in pancreatic carcinogenesis.
In the large intestine and to a lesser extent in the small bowel and stomach, we and other have shown that dietary or surgical manipulations causing increased cell proliferation will generally enhance experimental carcinogenesis, whereas atrophy has a protective effect (Oscarson et al., 1979; Rainey et al., 1983; Williamson & Rainey, 1984; Houghton et al., 1987) . The present review examines the hypothesis that hyperplasia and neoplasia are similarly linked in the exocrine pancreas. Since few data exist in man, we are primarily concerned with events in rodent models of pancreatic carcinogenesis. Broadly speaking there are three types of model:
(1) Hamsters given BOP (N-nitrosobis (2-oxopropyl)amine) and related nitrosamines develop ductal adenocarcinomas that resemble the predominant histological pattern of 'spontaneous' human cancer (Pour et al., 1977; Scarpelli et al., 1984) .
(2) Rats given azaserine develop atypical acinar cell foci (AACF) of acidophilic type which lead on to acinar cell carcinomas (Longnecker, 1984) . Although true acinar cell carcinoma is rare in man, there is a substantial body of evidence to suggest that acinar cells dedifferentiate to ductal/ ductular cells during the process of carcinogenesis (Flaks, 1984) .
(3) Transgenic mice have been bred with a high incidence of spontaneous development of pancreatic acinar cell tumours and islet cell tumours (Ornitz et al., 1987; Longnecker et al., 1990; Bell et al., 1991) .
Effects of dietary manipulation (Table I) Protease inhibitors
(1) Natural The discovery that diets containing raw soya flour cause enlargement of the rat pancreas within 9 days opened up the field of experimental pancreatic hyperplasia and neoplasia (Rackis, 1965 Crass & Morgan, 1982; McGuiness et al., 1982; Oates & Morgan, 1982) . In a long-term study, McGuiness and colleagues (1980) Oates & Morgan, 1982) . Pancreatic hyperplasia and accelerated cell proliferation were shown by greater protein and nucleic acid contents plus increased thymidine uptake; duct cell labelling was increased 11-fold and acinar cell labelling two-fold. The heat-labile tropic factor was thought to be soybean trypsin inhibitor (Rackis, 1965) . When plasma from rats fed 1.8-2.0% semipurified soybean trypsin inhibitor was perfused through an isolated rat pancreas, amylase secretion increased by a factor of two-to-three (Khayambashi & Lyman, 1969) . Feedback inhibition of pancreatic enzyme secretion by intraluminal trypsin is itself switched off by protease (trypsin) inhibitors (Green & Lyman, 1972) . A humoral mechanism is involved (Green et al., 1973) . Circulating concentrations of cholecystokinin (CCK) are trebled and concentrations of gastrin are increased by about 50% in rats fed raw soya flour (Adrian et al., 1982) . Intragastric instillation of soybean trypsin inhibitor causes a 30-fold increase in circulating CCK (Liddle et al., 1984) . Both gastrin and CCK stimulate pancreatic growth in the rat (Mainz et al., 1973; Brants & Morisset, 1976; Ihse et al., 1976; Reber et al., 1977; Folsch et al., 1978; Peterson et al., 1978; Dembinski & Johnson, 1979) and therefore seem likely to mediate pancreatic growth after soybean feeding.
In rats at least, raw soya flour may also enhance carcinogenesis in the pancreas. A higher yield of carcinomas was found in rats given the carcinogen di(2-hydroxypropyl) nitrosamine (DHPN) (Levison et al., 1979) . Using a different pancreatic carcinogen (azaserine) in subthreshold doses, McGuiness and colleagues (1981) had a less clear-cut result. The volume of neoplastic lesions in the rat pancreas was much greater after feeding raw as opposed to heated flour, but the proportion of affected animals with such lesions was similar (65 vs 60%). Moreover, there are species differences. Mice fed raw soya flour for 18 months had an enlarged pancreas but were relatively resistant to the carcinogenic effects of azaserine, whereas hamsters fed such diets for 15 months did not exhibit pancreatic enlargement and had a low tumour incidence (< 10%) after exposure to BOP (Liener & Hasdi, 1986) . Pancreatic contents of DNA, RNA and protein were unchanged by feeding raw soya flour to monkeys and were almost unchanged in pigs (Struthers et al., 1983). (2) Synthetic (camostate) Camostate, a synthetic guanidino acid ester, is a potent inhibitor of several enzymes: trypsin, kallikrein, plasmin, thrombin, complement protein (CI) esterase and phospholipase A2 (Muramatu & Fujii, 1972; Tamura et al., 1977; Freise et al., 1983) . Like soybean trypsin inhibitor, camostate will increase circulating CCK concentrations and stimulate pancreatic growth in rats when added to the diet (Goke et al., 1986; Otsuki et al., 1987; Wisner et al., 1988; Douglas et al., 1989; Douglas et al., 1990b (Wisner et al., 1988; Douglas et al., 1989; Douglas et al., 1990b) .
Again like the natural protease inhibitor, camostate markedly increases the development of acidophilic AACF in rat pancreas after azaserine administration, while CR-1409 inhibits the hyperplasia and enhanced neoplasia (Douglas et al., 1989) . Similar pancreatic hyperplasia and hypercholecystokininaemia follow camostate feeding in mice (Niederau et al., 1987) and hamsters (Douglas et al., 1990b) (Roebuck et al., 1981a and 1981b) . Likewise, administration of corn oil by gavage (5-10 ml kg-' 5 days per week) causes a modest increase in the yield of acinar cell nodules and adenomas compared with standard chow (Boorman & Eustis, 1984) . We have investigated the effects of individual fatty acids (stearic and oleic acid) on the development of acidophilic AACF (the precursors of pancreatic carcinoma) (Khoo et al., 1991) . Six months after initiation with carcinogen the number and volumetric indices of acidophilic AACF were increased in rats fed oleic acid (but not stearic acid); examining total lipid extracts of the pancreas showed a higher oleic acid content at the expense of all other fatty acids in the pancreas. Roebuck and colleagues showed an increase in the number and size of acidophilic AACF as the EFA (essential fatty acid) content of the diet was increased. (Roebuck et al., 1985) . The minimum proportion of dietary essential fatty acids required for tumour enhancement lay in the range of 4 to 8%. Diets rich in saturated fat (20% lard) will also enhance carcinogenesis, and this effect is not related to a higher caloric intake (Appel et al., 1990) . The concentrations of EFA used in this study were 3% or less, and supplementation with the EFA linoleic acid did not affect tumour yields in the low-fat group.
High-fat diets and particularly those enriched with unsaturated fatty acids will also enhance the development of pancreatic cancer in the BOP-hamster model (Birt et al., 1981) .
To avoid the effect of variation in total caloric intake, Birt and colleagues (1989) conducted another experiment in which high-fat diets (20.5% corn oil) were given either ad libitum or by pair-feeding. Pair-fed hamsters receiving the high-fat diet or a low-fat diet (4.3% corn oil) had equivalent calorie intakes. Pancreatic carcinogenesis was increased two-to-four fold when hamsters were fed a high-fat diet by either protocol, and the degree of enhancement did not differ with the feeding regimen. As in rats, so in hamsters given BOP diets high in saturated fatty acids (20% lard) enhance the formation of putative preneoplastic lesions (intermediate ductal complex or tubular ductal complex) (Woutersen & van Gerderen-Hoetmer, 1988) .
Dietary fat can also affect the development of pancreatic carcinomas in elastase 1-simian virus 40 T transgenic mice. Animals fed either of the purified diets (containing 5% or 20% corn oil) developed a higher incidence of exocrine carcinomas than those fed how, but the level of fat in the diets (5% vs 20%) did not alter tumour incidence (Longnecker et al., 1990) . Interestingly, male mice developed more exocrine carcinomas than female mice and their tumours were larger, but a higher incidence of islet cell tumours was found in females irrespective of diet.
The mechanism by which unsaturated fatty acids affect the pancreas is uncertain. Intragastric feeding of various fatscorn oil, beef tallow, fish oil and medium-chain triglycerides -will each increase circulating CCK levels in rats (Douglas et al., 1990a) . However, since high-fat diets did not induce pancreatic growth in one rat study (Roebuck et (Longnecker, 1990) .
Protein
Since the growth-stimulating properties of raw soya flour on the pancreas are greatly increased by supplementing the diet with essential amino acids (Booth et al., 1960) (Green et al., 1991) .
Although the number of pancreatic neoplasms (adenomas and carcinomas) at 1 year was reduced by a high-protein (50% casein) diet in one experiment using the rat-azaserine model (Roebuck et al., 1981a) , the concentration of protein chosen did not affect pancreatic weight. In the BOP-hamster model, the incidence of pancreatic carcinomas did increase with rising levels of dietary protein (at least in females), when either 9% or 36% protein was given during the postinitiation phase of carcinogenesis (Pour & Birt, 1983 ). There appears to be some interaction between dietary levels of protein and fat, since a high protein diet will not enhance pancreatic carcinogenesis when the fat content is low (Birt et al., 1983b) . These data are consistent with the finding that dietary protein and CCK work synergistically to stimulate pancreatic growth.
Other specific dietary constituents
Retinoids Various types of retinoid will inhibit azaserine carcinogenesis in rats. There are fewer acidophilic AACF at 4 months (Roebuck et al., 1984) and fewer frank neoplasms at 1 year after initiation (Longnecker et al., 1982) . However, different retinoids have different efficacy. Thus retinylidene dimedone, N-2-hydroxyethylretinamide and N-4-propionyloxphyenylretinamide had a greater effect (at 1 year) than N-4-carboxyphenylretinamide (Longnecker et al., 1982) .
Hamsters generally tolerate retinoids poorly and lower doses are required. This fact may explain the divergent reports of their effects on pancreatic carcinogenesis, including greater tumour yields (Birt et al., 19883a) , reduced yields (Longnecker et al., 1986) and unchanged yields (Longnecker et al., 1983 (Webster et al., 1972; Brand & Morgan, 1981; Nagy et al., 1989) , and refeeding restores these indices of organ mass (Webster et al., 1972) . Cell proliferation is also impaired by fasting, with decreased incorporation of tritiated thymidine into DNA (in rat pancreas) at 48 h (Solomon, 1986) . Roebuck and col- leagues studied the effect of caloric intake on pancreatic carcinogenesis in rats initiated with azaserine and found that rats with caloric restriction (to 90% of control consumption) had no pancreatic neoplasms at 7.5 months, while 24% of controls had tumours (Roebuck et al., 1981b) . Thus reduced caloric intake will protect against experimental pancreatic carcinogenesis as it does in many other organs. The underlying mechanism is unknown; reduced levels of carcinogenactivating enzymes in the pancreas or reduced tropic stimuli to the gland are plausible hypotheses (Longnecker, 1990 ).
Effects of surgical manipulation (Table II cholecystokinin. Both 1 week and 1 month after 90% proximal small bowel resection, 5-72% increments in pancreatic mass correlated with 83-150% increments in enteroglucagon levels, while neurotensin levels were unchanged (Watanapa et al., 1991a) . CCK proved to be another candidate for the role of pancreatotropin. Circulating levels were doubled 3 weeks after massive enterectomy, and the specific CCK receptor antagonist CR-1409 (lorglumide) completely prevented the effect on pancreatic growth (Watanapa et al., 1992b) .
The actions of enteroglucagon and CCK are closely linked.
Enteroglucagon plays a major role in modulating the compensatory hyperplasia seen in the remaining small bowel after partial enterectomy (Bristol & Williamson, 1988) . The duodenum participates in this adaptive response to proximal small bowel resection (Williamson & Bauer, 1978; Urban et (Stewart et al., 1991) , probably because severe weight loss and malabsorption suppressed carcinogenesis (Roebuck et al., 1981b) . Thus the stimulatory effect of operation might be balanced by the inhibitory effect of caloric restriction.
Ileocaecal resection produces hyperplasia and hypertrophy in rat pancreas at 4 weeks (Baba et al., 1985) . Again humoral changes could be involved, but so could another mechanism, namely a deficiency in the bile acid pool resulting from interruption of the enterohepatic circulation. In support, reducing luminal concentrations of bile acids either by administering cholestyramine (a binding agent) or by ligating the bile duct will increase pancreatic mass in rats (Brand & Morgan, 1982; Baba et al., 1983 (Gomez et al., 1990) . Moreover, all the tropic effects of cholestyramine on the pancreas are completely abolished by the administration of the specific CCK antagonist L-364,7 18. As for pancreatic carcinogenesis, a 2% cholestyramine supplement will potentiate the action of azaserine (by increasing the yield of acidophilic AACF) but only in rats given heated soya flour and not raw flour (Morgan et al., 1990) .
Two independent groups from Germany have reported pancreatic growth following truncal vagotomy in rats Buchler et al., 1987; Buchler et al., 1988) . Koop and colleagues found that basal gastrin was increased after vagal section, but the levels did not correlate with the degree of exocrine pancreatic hyperplasia . Biichler and colleagues measured both basal and postprandialplasma CCK and gastrin; CCK levels were unchanged, whereas basal and postprandial gastrin levels were increased (Buchler et al., 1988) . In the hamster, truncal vagotomy enhances pancreatic carcinogenesis; changes in bile acid composition may be involved (Ogawa et al., 1991) .
Gastrectomy, whether total or subtotal, will also produce pancreatic hyperplasia with increased organ mass at 2-4 weeks Biichler et al., 1988) . In our own study rats with 60% distal gastrectomy had more (and larger) acidophilic AACF than controls 15 months after exposure to azaserine. Unlike Malfertheiner, we found higher plasma CCK concentrations, both basal and postprandial (Watanapa et al., 1992e) . Thus CCK could act as an intermediary for the stimulatory effects of partial gastrectomy on the pancreas, especially since antral resection would reduce gastrin output.
If complete duodenogastric reflux is produced in rats by means of a split gastrojejunostomy, numerous hyperplastic nodules plus some adenomatous nodules develop in the pancreas approximately 1 year after the operation (Taylor et al., 1989) . We have further investigated the effect of duodenogastric reflux on pancreatic growth and chemical carcinogenesis. Six months after split gastrojejunostomy rats had greater pancreatic weight, and only those with duodenogastric efflux showed any preneoplastic foci after azaserine treatment (Watanapa et al., 1992c) . On this occasion plasma CCK levels were unchanged, while both basal and postprandial plasma gastrin levels were increased by split gastrojejunostomy. In summary, both vagotomy and duodenogastric reflux stimulate pancreatic growth in association with hypergastrinaemia. Partial gastrectomy (which causes both partial vagotomy and some degree of duodenogastric reflux) has a similar effect on the pancreas, and this is mediated not by gastrin but possibly by CCK. Cholecystectomy has been reported to stimulate pancreatic growth in hamsters and to increase plasma CCK concentrations 2-4 weeks after the operation (Rosenberg et al., 1983; Rosenberg et al., 1984) . However, 30 weeks after initiation with BOP, hamsters with cholecystectomy had similar pancreatic weights and tumour yields to unoperated controls (Chester et al., 1989) . Experimental diversion of pancreatobiliary secretions to the mid small bowel (pancreatobiliary diversion) in rats causes (1) hyperplasia of the mucosa of the transposed jejunal segment (Miazza et al., 1992) , (2) increased plasma CCK concentrations and (3) marked and sustained growth of the pancreas (Miazza et al., 1987) . Longterm pancreatobiliary diversion (PBD) causes nodule formation in the rat pancreas, both hyperplastic and adenomatous nodules (Stace et al., 1987) . PBD not only stimulates pancreatic acinar cell growth, but also increases the proliferative activity of the ductular cells (Gasslander et al., 1991) . Subsequent studies using a specific CCK receptor antagonist (either CR-1409 or L-364,718) confirm a major role for CCK in the adaptive response of the rat pancreas to PBD (Axelson et al., 1990; Gasslander et al., 1990; Watanapa et al., 1991b ).
In our own laboratory, 6 months after azaserine treatment PBD greatly increased the incidence of pancreatic preneoplastic lesions and quadrupled circulating levels of CCK (Stewart et al., 1991; Watanapa et al., 1992d The use of animal models has traditionally provided much information on the aetiology of many cancers. Together with epidemiological studies in man and in vitro experiments, animal work is the third major source of such information. In Japan, where the incidence of pancreatic cancer has more than quadrupled over the past 40 years, the data suggest a correlation with soybean intake (Hirayama, 1989) . The relative risk of pancreatic cancer for those who consume soybean soup occasionally is 1.52, compared to 1.00 in those who never consume it. The relative risk rises to 1.77 in those taking soybean soup every day. Though most of the trypsin inhibitor activity in some traditional Oriental soya foods is removed or inactivated during processing and the remainder is further reduced during cooking, the Japanese food 'miso' is an exception. Miso is a fermented soya product used in cooking, particularly in soups. It contains a high concentration of free fatty acids (39% as opposed to 0.5% in other common soya products), which are believed to act as a heat-stable trypsin inhibitor (the usual specific soybean trypsin inhibitors are proteins) (Doell et al., 1981) . CCK may also be involved since raw soybean flour causes a nearly four-fold increase in circulating CCK levels in man as opposed to heat-treated flour (Calam et al., 1987) . Total fat intake has also been shown to correlate positively with mortality rates from pancreatic cancer (Lea, 1967; Wynder et al., 1973; Gordis & Gold, 1984) despite similar body weights between controls and patients with pancreatic carcinoma (Wynder et at., 1973 (Mack et al., 1986) . They found a strong association between pancreatic cancer and a history of previous peptic ulcer surgery (both partial gastrectomy and vagotomy with pyloroplasty), with a relative risk factor of 7.0. Two subsequent epidemiological studies have confirmed this positive link, showing a risk factor of 3.4 and 4.0 (Caygill et al., 1987; Mills et al., 1988) . None of these three reports distinguished between gastrectomy and vagotomy as the causative factor. However, a case-control study on autopsy subjects showed a three-fold risk of pancreatic cancer in postgastrectomy patients (Offerhaus et al., 1987) . Schlag and colleagues (1980) studied the effect of gastric operations for peptic ulcer disease in 44 patients at least 2 years after the operation. They demonstrated increased levels of nitrites and n-nitroso compounds in the remaining stomach (after either Billroth I and II resections), but these substances were not increased after proximal gastric vagotomy, which preserves the pyloric sphincter mechanism. Their subsequent study also showed unchanged levels of these substances in unoperated stomachs with atrophic gastritis (Schlag et al., 1982) . Thus partial gastrectomy and duodenogastric reflux seem to be involved in n-nitrosation in the operated stomach. These nitrites and n-nitroso compounds can act as pancreatic carcinogens. They could be absorbed and subsequently secreted into the pancreatic juice or might reflux from the duodenum into the pancreatic duct, thereby inducing pancreatic cancer. These operations may increase pancreatic growth as a consequence of hypercholecystokininaemia (after gastrectomy) or hypergastrinaemia (after procedures that produce duodenogastric reflux such as vagotomy with pyloroplasty). This hyperplasia combined with greater exposure to pancreatic carcinogens might explain the increase in pancreatic cancer risk after peptic ulcer surgery.
A retrospective epidemiological study in 100 males and 42 females with pancreatic cancer demonstrated a positive relationship between pancreatic cancer and cholecystectomy in females (Wynder et al., 1973) . However, a subsequent study failed to confirm this increased risk (Mack et al., 1986) . A massive small bowel resection is rarely performed in man, and those who survive the operation might not live long enough to develop pancreatic cancer (if there is any increased risk). Therefore the relationship between enterectomy and pancreatic cancer is still unknown, and no excess has been reported after ileocaecal resection.
Multiple genetic events have been shown to be necessary for neoplastic transformation, and several complementary molecular abnormalities have been described in human pancreatic cancer. The Kirsten ras oncogene at codon 12, overexpression of the epidermal growth factor receptor and abnormalities of c-erbB-2 expression are demonstrated in 20-90% of patients with pancreatic cancer (Gullick et al., 1987; Almoguera et al., 1988; Kloppel et al., 1989) . In BOPinduced pancreatic adenocarcinomas in hamsters, activation of the c-Ki-ras by point mutation (G-A transitions of the second base) has been reported in codon 12 and 13 (Cerny et al., 1990; Fujii et al., 1990; van Kranen et al., 1991) , but such changes are not found in pancreatic tumours (including adenomas, carcinomas in situ and adenocarcinomas) of rats receiving azaserine (Schaeffer et al., 1990; van Kranen et al., 1991) . Therefore the data from carcinogenesis experiments may only be of tentative relevance to the human situation. However, the consistent effect of nutrient intake and some common operations on pancreatic cancer risk in animals and man would support further research in this area. Although care must be taken in extrapolating from narrowly-focused animal studies to free-living human populations, the carcinogenesis models do allow us to explore specific mechanisms in great detail. The fact that less is known about the cause of pancreatic cancer than almost any other common abdominal cancer is sufficient justification to continue this exploration. CRASS, R.A. & MORGAN, R.G.H. (1982) . The effect of long-term feeding of soya-bean four diets on pancreatic growth in the rat. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis (2-oxopropyl) amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol. Carcinog., 3, 296-301.
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